Metabolic effects of FK 506 (tacrolimus) versus cyclosporine in portally drained pancreas allografts.
Elmer
D S
DS
Department of Surgery, University of Tennessee, Memphis 38163, USA.
Abdulkarim
A B
AB
Fraga
D
D
Shokouh-Amiri
H
H
Stratta
R J
RJ
Hathaway
D K
DK
Reddy
K
K
Gaber
A O
AO
D016572:Cyclosporine / Q000008:administration & dosage*; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000378:metabolism / Q000601:surgery*; D004322:Drainage; D005260:Female; D005947:Glucose / Q000378:metabolism*; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D006943:Hyperglycemia / Q000209:etiology / Q000517:prevention & control; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D008297:Male; D016035:Pancreas Transplantation; D011168:Portal System / Q000601:surgery; D016559:Tacrolimus / Q000008:administration & dosage*; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D005947:Glucose; D016559:Tacrolimus